首页> 外国专利> HYBRID CYTOKINE WITH PARTS FROM AT LEAST 2 OF LEUKAEMIA INHIBITORY FACTOR (LIF), GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF), INTERLEUKIN-6 AND ONCOSTATIN-M

HYBRID CYTOKINE WITH PARTS FROM AT LEAST 2 OF LEUKAEMIA INHIBITORY FACTOR (LIF), GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF), INTERLEUKIN-6 AND ONCOSTATIN-M

机译:混合细胞因子,含至少两种白血病抑制因子(LIF),粒细胞-结肠刺激因子(G-CSF),白细胞介素-6和癌抑素-M

摘要

Hybrid cytokines containing four helical regions, each of which is derived from a corresponding alpha-helical region in leukemia inhibitory factor (LIF), granulocyte colony stimulating factor (G-CSF), interleukin-6 (IL-6) or oncostatin-M (OSM) are disclosed. These hybrid cytokines may further contain linking regions also derived from corresponding linking regions in these factors. The hybrid cytokines offer a unique spectrum of activities useful in treating conditions for which the native cytokines are useful or in treating conditions characterized by an excess of the native cytokines.
机译:包含四个螺旋区的杂交细胞因子,每个螺旋区均来自白血病抑制因子(LIF),粒细胞集落刺激因子(G-CSF),白介素6(IL-6)或抑瘤素M( OSM)。这些杂种细胞因子可进一步包含也源自这些因子中相应连接区域的连接区域。杂种细胞因子提供了独特的活性谱,可用于治疗天然细胞因子有用的病症或用于治疗以天然细胞因子过量为特征的病症。

著录项

  • 公开/公告号NZ244155A

    专利类型

  • 公开/公告日1994-11-25

    原文格式PDF

  • 申请/专利权人 FRED HUTCHINSON CANCER RESEARCH CENTER;

    申请/专利号NZ19920244155

  • 发明设计人 TODARO GEORGE JOSEPH;ROSE TIMOTHY MICHAEL;

    申请日1992-08-31

  • 分类号C07K13/00;C07K15/00;C07K15/06;C12N15/19;C12N15/24;C12N15/11;C12N15/12;C12N15/63;C12N1/15;C12N1/21;C12N5/10;A61K37/02;C12P21/02;

  • 国家 NZ

  • 入库时间 2022-08-22 04:18:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号